Abstract:SUMMARY: Esophageal cancer is one of the most aggressive gastrointestinal cancers. Invasion and metastasis are the main causes of poor prognosis of esophageal cancer. SPRY2 has been reported to exert promoting effects in human cancers, which controls signal pathways including PI3K/AKT and MAPKs. However, the expression of SPRY2 in esophageal squamous cell carcinoma (ESCC) and its underlying mechanism remain unclear. In the present study, we aimed to investigate the detailed role of SPRY2 in the regulation of cell proliferation, invasion and ERK/AKT signaling pathway in ESCC. It was identified that the expression level of SPRY2 in ESCC was remarkably decreased compared with normal tissues, and it was related to clinicopathologic features and prognosis ESCC patients. The upregulation of SPRY2 expression notably inhibited the proliferation, migration and invasion of Eca-109 cells. In addition, the activity of ERK /AKT signaling was also suppressed by the SPRY2 upregulation in Eca-109 cells. Our study suggests that overexpression of SPRY2 suppress cancer cell proliferation and invasion of by through suppression of the ERK/AKT signaling pathways in ESCC. Therefore, SPRY2 may be a promising prognostic marker and therapeutic target for ESCC. RESUMEN: El cncer de esfago es uno de los cnceres gastrointestinales ms agresivos. La invasin y la metstasis son las principales causas de mal pronstico del cncer de esfago. Se ha informado que SPRY2 ejerce efectos promotores en los cnceres humanos, que controla las vas de seales, incluidas PI3K/AKT y MAPK. Sin embargo, la expresin de SPRY2 en el carcinoma de clulas escamosas de esfago (ESCC) y su mecanismo subyacente an no estn claros. En el presente estudio, nuestro objetivo fue investigar el papel detallado de SPRY2 en la regulacin de la proliferacin celular, la invasin y la va de sealizacin ERK/AKT en ESCC. Se identific que el nivel de expresin de SPRY2 en ESCC estaba notablemente disminuido en comparacin con los tejidos normales, y estaba relacionado con las caractersticas clnico-patolgicas y el pronstico de los pacientes con ESCC. La regulacin positiva de la expresin de SPRY2 inhibi notablemente la proliferacin, migracin e invasin de clulas Eca-109. Adems, la actividad de la sealizacin de ERK/AKT tambin fue suprimida por la regulacin positiva de SPRY2 en las clulas Eca-109. Nuestro estudio sugiere que la sobreexpresin de SPRY2 suprime la proliferacin y la invasin de clulas cancerosas mediante la supresin de las vas de sealizacin ERK/AKT en ESCC. Por lo tanto, SPRY2 puede ser un marcador de pronstico prometedor y un objetivo teraputico para la ESCC.

Loss of SPRY2 contributes to cancer-associated fibroblasts activation and promotes breast cancer development

Cancer-Associated Fibroblasts Suppress Cancer Development: The Other Side of the Coin

Sprouty genes regulate activated fibroblasts in mammary epithelial development and breast cancer

Cancer‐associated Fibroblasts in Breast Cancer: Challenges and Opportunities

Suppression of Spry1 Inhibits Triple-Negative Breast Cancer Malignancy by Decreasing EGF/EGFR Mediated Mesenchymal Phenotype

Suppression of Spry4 Enhances Cancer Stem Cell Properties of Human MDA-MB-231 Breast Carcinoma Cells.

Lower Expression of SPRY4 Predicts a Poor Prognosis and Regulates Cell Proliferation in Colorectal Cancer.

Sprouty2 Correlates with Favorable Prognosis of Gastric Adenocarcinoma Via Suppressing FGFR2-induced ERK Phosphorylation and Cancer Progression

Overexpression SPRY2 Suppresses Esophageal Squamous Cell Carcinoma Progression Via Inactivation of ERK/AKT Signaling

Tumor fibroblast-derived FGF2 regulates expression of SPRY1 in esophageal tumor-infiltrating T cells and plays a role in T cell exhaustion

SFRP1 mediates cancer-associated fibroblasts to suppress cancer cell proliferation and migration in head and neck squamous cell carcinoma

Overexpression of Cancer Upregulated Gene 2 (CUG2) Decreases Spry2 Through c-Cbl, Leading to Activation of EGFR and β-Catenin Signaling

EZH2-mediated Epigenetic Suppression of Long Noncoding RNA SPRY4-IT1 Promote S NSCLC Cell Proliferation and Metastasis by Affecting the Epithelial–mesenchymal Transition

NF-κB-activated SPRY4-IT1 promotes cancer cell metastasis by downregulating TCEB1 mRNA via Staufen1-mediated mRNA decay

Role of SPRY4 in health and disease

The Role of Sprouty1 in the Proliferation, Differentiation and Apoptosis of Epidermal Keratinocytes

The Long Noncoding RNA SPRY4-IT1 Increases the Proliferation of Human Breast Cancer Cells by Upregulating ZNF703 Expression

Sprouty2 Suppresses Progression And Correlates To Favourable Prognosis Of Intrahepatic Cholangiocarcinoma Via Antagonizing Fgfr2 Signalling

Low SCRIB expression in fibroblasts promotes invasion of lung cancer cells

Novel Tumor Suppressor SPRYD4 Inhibits Tumor Progression in Hepatocellular Carcinoma by Inducing Apoptotic Cell Death

Decreased Long Noncoding RNA SPRY4-IT1 Contributing to Gastric Cancer Cell Metastasis Partly Via Affecting Epithelial–mesenchymal Transition